Nicotine-antipsychotic drug interactions and attentional performance in female rats.
D000818:Animals; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology*; D001288:Attention / Q000187:drug effects* / Q000502:physiology; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000494:pharmacology*; D003024:Clozapine / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D005260:Female; D006220:Haloperidol / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology; D009538:Nicotine / Q000008:administration & dosage / Q000494:pharmacology*; D010775:Photic Stimulation; D011597:Psychomotor Performance / Q000187:drug effects* / Q000502:physiology; D051381:Rats; D017207:Rats, Sprague-Dawley; D018967:Risperidone / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000494:pharmacology
D014150:Antipsychotic Agents; D000697:Central Nervous System Stimulants; D009538:Nicotine; D003024:Clozapine; D006220:Haloperidol; D018967:Risperidone